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.2012.07.Abstract Background: There is evidence in literature that chronic hepatic patients need less anes-
thesia compared with healthy ones. Liver cirrhosis leads to a reduction in liver mass and hepatic
blood ﬂow with an effect on drug clearance and cardiovascular stability.
Aim: To evaluate sevoﬂurane consumption during entropy monitored general anesthesia in cir-
rhotic and non-cirrhotic patients during transition from consciousness to unconsciousness and
throughout the procedure of major hepatic surgical procedures.
Patients and methods: Forty patients scheduled for major hepatic resection at the National Liver
Institute, Menoﬁya University, Egypt, were studied prospectively and randomized into two equal
groups. Group I (n. 20) cirrhotic patients (Child Pugh Grade A) with focal lesion, Group II (n.
20) healthy live liver donors undergoing major hepatectomies. Sevoﬂurane inhalational concentra-
tion was adjusted to achieve a state and response entropy of 40–60, and when RE increases 5–10
units above SE; more intravenous analgesics were given.
Results: Mean (SD) Sevoﬂurane consumption in Group II showed higher consumption 23.5 (3.23)
ml, compared to Group I 16 (2.19) ml. Mean (SD) sevoﬂurane consumption after 4 and 6 h from
induction also showed a lower value in Group I 10.7(1.94), 9(1.22) ml, than in Group II 17.2(1.69),
14.1(2.19) ml, respectively. Mean (SD) end tidal sevoﬂurane concentration was lower in Group I
1.4(0.12) after 2 h from induction than in Group II 1.7(0.11). After 4 and 6 h from induction Group
I demonstrated a lower value compared to Group II (P < 0.05.). Mean blood pressure, heart rate,Elmahasen Elshasely square,
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62 E.K. Refaat, T.E. Yasseinurine output and CVP showed no signiﬁcant changes during maintenance between the two groups.
Conclusion: This study demonstrated that cirrhotic patients require less sevoﬂurane consumption
and lower end-tidal concentration to maintain general anesthesia with entropy guidance. This could
also have an important impact on the economic costs when applied on a larger scale.
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Anesthesia is a balance between the amount of anesthetic
drugs administered and the state of arousal of the patient, gi-
ven that the intensity of surgical stimulation varies throughout
surgery, and the hemodynamic effects of the anesthetic drugs
may limit the amount that can be given safely, it is not uncom-
mon for there to be critical imbalances between anesthetic
requirements and anesthetic drug administration. Underdosing
may be due to equipment failure or an error [1]. Conversely,
inappropriate titration of the hypnotic components, leading
to an excessive depth of anesthesia (DOA), might compromise
patient outcome [2]. Patient movement in response to noxious
stimulation remains an important sign of inadequate DOA,
but is unreliable [3] and is suppressed by paralysis. Traditional
clinical signs such as hypertension, tachycardia and lacrima-
tion are unreliable indicators of DOA [4]. Monitoring anes-
thetic depth make it possible to administer the appropriate
dose of anesthetics and prevent anesthetic awareness, side-
effects of over-dosage, and economic and environmental waste.
Therefore, anesthetic management, using proper anesthetic
administration, is equally important as maintaining vital signs
of the patient. Entropy monitoring allows for the quantiﬁca-
tion of cerebral neural activity. The increase and decrease in
entropy scores are related to the level of consciousness under
anesthesia. EEG entropy is an entropy monitor based on
EEG analysis used in measuring hypnosis levels [5]. EEG-
entropy has two signals: State entropy (SE) receives infor-
mation from the brain waves and response entropy (RE)
incorporates information from the frontal electromyography.
SE is computed using EEG data from the previous 15 s,
between 0.8 and 32 Hz, and shows the value in the range of
0–91. RE is computed from 32 to 47 Hz with 1.92 s, and
reﬂects fast muscular activity from the frontal muscle, and
shows the value in the range of 0–100. [6]
In Egypt, cirrhosis is mostly due to bilharzial peri-portal
hepatic ﬁbrosis or repeated viral attacks leading to chronic
hepatitis. The death rate due to liver cirrhosis in Egypt is not
exactly known due to deﬁcient statistical evaluation [7].
Preoperative recognition of compensated or occult liver dis-
ease is important, because stresses of anesthesia and surgery
can precipitate overt hepatic dysfunction in those patients.
So, patients with liver disease pose major challenges in operat-
ing room and intensive care units. A comprehensive under-
standing of the liver problem is a must for doctors dealing
with patients in these two locations [8].
In this study we maintained the appropriate anesthetic
depth for patients undergoing entropy-monitored hepatic sur-
gery where anesthetic depth was controlled by both titrating
the concentration of the inhaled anesthetic–sevoﬂurane and
entropy monitoring. We attempted to compare sevoﬂurane
consumption and end-tidal concentration when using continu-ous infusion of sevoﬂurane in cirrhotics and non-cirrhotics
undergoing major hepatic surgery.
2. Patients and methods
After obtaining written informed consent and approval of the
local ethics and research committee at the Menoﬁya Univer-
sity, Egypt. This prospective randomised study was conducted
at the Anaesthesia Department of the National Liver Institute,
Menoﬁya University. It included forty patients from both
sexes who underwent a major hepatic surgery.
Exclusion criteria included; patients with known neurologic
or psychiatric disorders, chronic use of anticonvulsant or other
centrally active medications, patients with clinically signiﬁcant
cardiovascular, respiratory or renal diseases, patients with
long-term drug or alcohol abuse and patients with body mass
index >40 (morbid obesity).
The forty patients were divided into two groups, each one
contained twenty patients. Group (I); cirrhotic patients (Child
Pugh Grade A) with hepatic focal lesion undergoing hepatec-
tomy, Group (II); healthy live liver donors undergoing graft
procurement.
On arrival to the operating theatre, standard monitors were
applied. Normothermia was maintained by forced-air warm-
ing. After the skin of the forehead was carefully wiped with
alcohol swab and then allowed to dry, the entropy disposable
sensor (three separate wet gel electrodes) was positioned as
recommended by the manufacturer entropy module of the
S/5e Anaesthesia Monitor by GE Healthcare Finland
(Datex-Ohmeda, Helsinki, Finland) in all groups. The sensor
was applied on the forehead one inch (2–3 cm) above
eyebrows. Number 1 at the midline of the forehead. Number
3 on the either template area between corner of eye and hair-
line. Number 2 in between the previous two electrodes. Sensor
edges were pressed to assure adhesion.
Recording of the biosignal from the patient’s forehead was
started while the patient was awake. The impedance for the en-
tropy sensor was checked and noted before induction. Baseline
heart rate and mean arterial blood pressure were obtained in
the operating room before induction of anesthesia.
After administration of 100% oxygen, anesthesia was in-
duced with propofol 2 mg/kg IV (propofol dose was adjusted
to achieve SE (40–60) and SE-RE difference less than 10). Fenta-
nyl 2 lg/kg IV and rocuronium 0.6 mg/kg IV was administered
to facilitate tracheal intubation. The patient was mechanically
ventilated tomaintain an end-tidal carbondioxide concentration
of 30–35 mmHg. Followed by sevoﬂurane 2% (initial inspired
concentration) in combination with air 50% in oxygen.
Intermittent bolus doses of rocuronium (0.05 mg/kg IV)
were administered according to the results of the train of four
(TOF). Subsequently, anesthesia was maintained with sevoﬂu-
rane and fentanyl.
Table 1 Clinical characteristics of the patients.
G1 G2 P-value
(n= 20) (n= 20)
Age (year) 47.9 ± 11.22 29.7 ± 8.52 <0.05
BMI (kg/m2) 26.7 ± 3.96 25.7 ± 3.31 <0.05
Propofal induction 156.6 ± 22.25 157.6 ± 25.42 <0.05
Dose (mg)
Duration of surgery 7.1 ± 0.3 7.5 ± 0.4 <0.05
Data are presented as mean ± SD. P < 0.05 is considered
signiﬁcant.
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to 91) and the response entropy (RE) (range from 0 to 100).
RE becomes equal to the SE when there is no electromyo-
graphic activity. Recommended range for adequate anesthesia
for both parameters is from 40 to 60, when SE increases above
60 the anesthetic drug dosage was increased. In contrast, if SE
was in the recommended range, but RE increases 5–10 units
above it, this is interpreted as a sign of uncovered nociception,
and more intravenous analgesic medication was required.
During maintenance, anesthesiologists were instructed to
adjust the sevoﬂurane concentration to keep SE, and RE val-
ues in the range of 40–60 by titrating 0.5 vol.% sevoﬂurane
every 5 min. Intermittent bolus doses of fentanyl 1–2 lg/kg
IV were given if the difference between RE and SE was more
than 10 for more than 2 min.
At the end of surgery, in both groups, anesthesia was
guided to achieve rapid recovery. Therefore, it was allowed
to accept state entropy values >60 in the period 15 min before
the end of surgery and the inhaled anesthetics was discontin-
ued, and residual neuromuscular blockade was reversed with
neostigmine 0.05 mg/kg IV and atropine 0.01 mg/kg IV.
Cases which needed massive blood transfusion and signiﬁ-
cant doses of rescue drugs were excluded from the study.
The mean arterial blood pressure, heart rate, SE, and RE
values were recorded before induction of anesthesia, at 5 min
intervals over 15 min period and at the end of surgery. The used
dosage of propofol at induction was recorded. End-tidal sevo-
ﬂurane, fentanyl dosage and sevoﬂurane consumption were
monitored 2, 4 and 6 h after induction of anesthesia. Central
venous pressure and the urine output were recorded every 2 h.3. Statistical analysis
Statistical analysis was done on a personal computer using the
IBM SPSS Statistics version 20 software (IBM Corpora-
tion, Armonk, NY, USA).
Normality of quantitative data distribution was tested
using the one-sample Kolmogorov–Smirnov goodness-of-ﬁt
test. Normally distributed quantitative data were presented
as mean (standard deviation) and between-group differences
were compared parametrically using the independent samples
Student t test.
All P values are two-tailed. P values <0.05 were considered
statistically signiﬁcant.
4. Results
The demographic data analysis showed that healthy living
donors (Group II) were signiﬁcantly younger compared with
patients in Group I. There were no statistical differences in
the patient weight or sex distribution. (Table 1) There was
no signiﬁcant change between Group I and Group II regarding
propofol consumption during induction (Table 1).
There was no signiﬁcant differences between the 2 studied
groups in mean arterial pressure and heart rate measurements
at the preinduction time, during the follow up times of mea-
surement at 5, 10 and 15 min after induction and at the end
of surgery. P > 0.05 (Table 2).
RE and SE were maintained in both groups between 40 and
60, and there were no signiﬁcant differences among subjects in
both groups (Table 2).When assessing sevoﬂurane consumption in the two studied
groups; there were signiﬁcant changes after 2 h from induction
in the studied groups. Group II showed a higher consumption
23.5 (3.23) ml, while Group I 16 (2.19) ml showed a lower con-
sumption (Table 3).
Sevoﬂurane consumption after 4 h from induction showed
a lower value in Group I 10.7 (1.94) ml, compared to Group
II 17.2 (1.69) ml. Also after 6 h from induction Group I 9
(1.22) showed a lower consumption value compared to Group
II 14.1 (3.02) ml.
End tidal sevoﬂurane; Group I showed a lower values after
2, 4 and 6 h from induction (1.4(0.12)%, 1.4(0.11)%, and
1.3(0.17)% respectively) compared to Group II (1.7(0.11)%,
1.6(0.07)% and 1.6(0.10)% respectively) (Table 3).
There was no signiﬁcant change between the two studied
groups in fentanyl consumption after 2, 4 and 6 h from induc-
tion P > 0.05 (Table 3).
Central venous pressure and urine output; showed no sig-
niﬁcant change between the two studied groups after 2, 4
and 6 h from induction P > 0.05 (Table 4).
5. Discussion
Maintaining anesthetic depth is essential during surgery to pre-
vent awareness and overdosage. Judging the depth of anesthe-
sia from observing the patient cardiovascular response and
titrating the dose of anesthetics was a common practice for
many years. The recent introduction of EEG-entropy as a
monitor for the depth of anesthesia and hypnosis lead to a
reduction in the incidence of unwanted perioperative events
such as hypertension, tachycardia or awareness throughout
general anesthesia [9] (see Table 5).
Entropy was used in the current study to monitor the titra-
tion of general anesthesia administration during hepatic resec-
tion surgery in cirrhotic and non-cirrhotic patients. Many
previous studies on healthy liver patients reported the inﬂuence
of the depth of anesthesia monitoring on the consumption of
hypnotic drugs and few studies monitored the effect on
cirrhotic patients.
Vakkuri et al. [10] stated that in sevoﬂurane-anesthesia, the
appropriate depth of anesthesia has the entropy value of 40–
60. In our study, sevoﬂurane concentration was adjusted so
that the entropy value was maintained between 40 and 60.
Comparisons of RE and SE between the two groups showed
no signiﬁcant differences, and they followed similar changes
with time.
Our current results showed that the end-tidal concentration
of sevoﬂurane to achieve a constant entropy range of 40–60
Table 2 Hemodynamics, state entropy and response entropy in both groups at the ﬁve measurement points.
Variable T1 T2 T3 T4 T5 P-value
MAP (mmHg)
GI 96.4 ± 3.34 94.3 ± 3.62 89.7 ± 3.81 86.7 ± 3.84 87.3 ± 3.22 <0.05
GII 94.5 ± 3.41 92.9 ± 3.24 89.2 ± 3.51 86.7 ± 3.85 89.2 ± 3.52
HR (beat/min)
GI 87 ± 12.32 89 ± 12.30 82 ± 9.72 77 ± 9.08 87 ± 11.39 <0.05
GII 92 ± 8.89 85 ± 8.91 80 ± 11.49 76 ± 10.87 89 ± 8.79
State entropy (SE)
GI 90 ± 0.63 61 ± 4.26 54 ± 6.58 42 ± 3.31 63 ± 4.22 <0.05
GII 90 ± 0.99 63 ± 4.79 52 ± 5.37 41 ± 3.62 60 ± 3.61
Response entropy (RE)
GI 100 ± 0.00 64 ± 4.18 53 ± 6.96 42 ± 3.22 62 ± 5.61 <0.05
GII 99 ± 0.63 65 ± 4.97 53 ± 5.62 41 ± 3.62 61 ± 4.20
Changes of mean arterial pressure (MAP), heart rate (HR), state entropy (SE) and response entropy (RE) in GI (Group I, cirrhotic patients) and
GII (Group II, healthy liver). Values are expressed as mean ± SD, P-value < 0.05 was considered statistically signiﬁcant. Before the induction
(T1), 5 min, 10 min and 15 min after induction (T2, T3 and T4) respectively, and at end of surgery (T5).
Table 3 Sevoﬂurane consumption, end-tidal sevoﬂurane and
fentanyl at 2, 4 and 6 h after induction.
Variable T1 T2 T3 P-value
Sevoﬂurane (ml)
GI 16 ± 2.19 10.7 ± 1.94 9 ± 1.22 <0.01
GII 23.5 ± 3.23 17.2 ± 1.69 14.1 ± 3.02
ET-sevo
GI 1.4 ± 0.12 1.4 ± 0.11 1.3 ± 0.17 <0.01
GII 1.7 ± 0.11 1.6 ± 0.07 1.6 ± 0.10
Fentanyl (lg)
GI 140 ± 50.7 80 ± 56.0 60 ± 54.7 <0.05
GII 153 ± 51.6 93 ± 59.3 63 ± 51.4
Sevoﬂurone, end-Tidal sevoﬂurane and fentanyl in the two studied
groups; GI (Group I, Cirrhotic patients) and GII (Group II,
healthy liver) values are expressed as mean ± SD. P-value < 0.05
is statistically signiﬁcant. The values are at 2, 4, and 6 h after
induction (T1, T2, and T3 respectively).
Table 4 Central venous pressure and urine output, measured
at 2, 4 and 6 h after induction in both groups.
Variable T1 T2 T3 P-value
CVP (cmH2O)
GI 5.4 ± 0.9 5.6 ± 0.7 6.3 ± 1.2 <0.05
GII 6.1 ± 1.2 6.1 ± 1.2 6 ± 0.65
UOP (ml)
GI 176 ± 24.1 178 ± 40.1 154 ± 45.6 <0.05
GII 171 ± 32.9 173 ± 44.5 161 ± 25.8
Central venous pressure (CVP) and urine output (UOP) in the two
studied group GI (Group I, cirrhoic patients) and GII (Group II,
healthy liver). Values are expressed as mean ± SD. P-value < 0.05
is considered signiﬁcant. The values measured at 2, 4 and 6 h after
induction (T1, T2 and T3) respectively.
Table 5 Liver functions in the two studied groups.
GI GII P-value
Albumin (gm/L) 3.5 ± 0.2 3.8 ± 0.6 <0.05
AST (iu/L) 51.3 ± 29.9 42.2 ± 20.46 <0.05
ALT (iu/L) 51.03 ± 29.9 34.9 ± 27.4 <0.05
INR 1.0 ± 0.7 1.0 ± 0.3 <0.05
Bilirubin (mg/dl) 1.26 ± 0.67 1.19 ± 159 <0.05
Data are presented as mean ± SD. P < 0.05 is considered signiﬁ-
cant AST, aspartate aminotransferase; ALT alanine aminotrans-
ferase; INR international normalized ratio.
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When compared with GI, the end-tidal sevoﬂurane concentra-
tion in GII was signiﬁcantly lower from 2 h after anesthesiainduction until the end of the operation. The results indicated
that the worse the liver function, the lower end-tidal concen-
tration of the sevoﬂurane was required to achieve the preset
entropy level. Regarding sevoﬂurane consumption in the two
studied groups; Group II showed the higher consumption,
while Group I showed the lower consumption after 2, 4 and
6 h from induction. Therefore in our study, provided that there
were no statistically signiﬁcant differences between both
groups regarding, weight, blood pressure or intraoperative
temperature, the cirrhotic patients had the lower sevoﬂurane
consumption and end-tidal concentration compared with
healthy livers (GI, live liver donors) who required the higher
sevoﬂurane consumption and end-tidal concentration to
achieve sufﬁcient anesthetic depth as monitored by the preset
value of entropy during hepatectomy.
The results of the current study were similar to a study
performed by Wang et al. [11], to assess factors inﬂuencing
the end-tidal concentrations of isoﬂurane within a bispectral
index (BIS) range of 45–55 among healthy live liver donors,
chronic hepatitis B patients undergoing hepatectomy for
hepatocellular carcinoma, and end-stage liver disease patients
undergoing liver transplantation. The study showed that end-
stage liver disease patients required the least end-tidal isoﬂu-
rane concentration. Patients with hepatocellular carcinoma
with cirrhosis required intermediate end-tidal isoﬂurane
concentrations; healthy live liver donors required the highest
end-tidal isoﬂurane concentrations to provide sufﬁcient
anesthetic depth. They concluded that liver function was the
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the end-tidal isoﬂurane concentration by 4 h after anesthesia
induction.
Kang et al. [12], conducted a study on the relationship be-
tween inhalational anesthetic requirements and the severity
of liver disease in liver transplant recipients according to
three phases of liver transplantation. The study included ﬁfty
patients undergoing living donor OLT were divided into two
groups: model for end-stage liver disease (MELD)
score < 20 versus MELD score > or = 20. ET desﬂurane
to maintain comparable anesthetic depth was signiﬁcantly
lower during the preanhepatic and anhepatic phases in the
high-MELD than the low-MELD group, but there was no
signiﬁcant difference during the post reperfusion period.
They concluded that OLT patients with high MELD scores
showed less inhalational anesthetic requirements during the
preanhepatic and the anhepatic periods than those with low
MELD scores.
The mechanisms for these differences are not clear. It has
been shown that, during inﬂammatory processes, cytokines
may trigger opioid-induced antinociception in peripheral opi-
oid receptors [13]. Interleukin 1 beta (IL-1_) or corticotro-
pin-releasing factor (CRF) is capable of producing
antinociception, which is believed to be caused by the release
of endogenous opioids, such as b-endorphin, dynorphin A,
and met-enkephalin.
In liver transplantation, posttransplantation require less
analgesia for postoperative pain relief [14]. Whether there
was less requirement of analgesic during the operation is not
clear. The mechanism why posttransplantation recipients re-
quire less analgesia was studied by Donovan et al. in humans
[14] and animals [15]. He found that among the pain-related
neuromodulators, only metenkephalin plasma levels, not beta-
endorphin and substance P plasma levels, were signiﬁcantly in-
creased both before and after liver transplantation when
compared with a control operation, thereby, subsequently
decreasing the analgesic requirement in the postoperative per-
iod [14,15]. In addition, inﬂammation caused by chemical in-
jury to the liver, tissue inﬂammation, and even acute stress
have been associated with increased plasma peptidase deriv-
able metenkephalin levels, which subsequently modulate pain
nociception [16]. Exogenous narcotics are known to reduce
the MAC of sevoﬂurane [17]. Whether endogenous neuropep-
tides modulate the MAC of sevoﬂurane is not clear; it needs
further biochemical studies.
The limitation of this study was the signiﬁcant difference in
age between the two studied groups which was inevitable
because the current study compare between liver cirrhotic
patients and healthy live donors of orthotopic liver trans-
plantation; but this difference were not felt to impact the noted
overall outcome of this prospective study.
In summary, during entropy monitored general anesthesia
with values between 40 and 06, cirrhotic patients showed lower
levels of sevoﬂurane consumption than non-cirrhotic patients.
The end-tidal concentration requirements of inhalational anes-
thetics were lower for patients with impaired liver status. The
use of entropy to monitor levels of end tidal inhalational anes-
thetics is helpful to avoid unnecessary high concentrations of
general anesthetics for cirrhotic patients which will prevent
the delay in recovery resulting from overdose and also to
reduce cost during prolonged surgical procedures.References
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